UPDATED May 08, 2024
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ASRT | US$1.06 | 4.5% | -86.2% | US$100.4m | US$3.00 | PB0.7x | E176.4% | n/a | ||
SNDL | US$2.46 | 8.4% | 50.9% | US$647.2m | US$3.61 | PB0.7x | E146.9% | n/a | ||
SBFM | US$0.99 | 15.1% | -98.1% | US$1.0m | US$15.00 | PB0.05x | E144.2% | n/a | ||
VCYT | US$20.12 | -0.3% | -14.7% | US$1.5b | US$30.60 | PS4.1x | E141.7% | n/a | ||
LFCR | US$6.65 | 3.3% | 47.5% | US$209.9m | US$6.00 | PS2x | E138.1% | n/a | ||
ETON | US$3.72 | -0.8% | 7.2% | US$95.6m | US$8.00 | PS3x | E128.8% | n/a | ||
MRVI | US$8.87 | 5.3% | -26.8% | US$2.3b | US$9.78 | PS4.1x | E126.7% | n/a | ||
NBY | US$0.089 | -0.7% | -90.9% | US$3.1m | US$2.60 | PB2.4x | E125.2% | n/a | ||
AMRX | US$6.59 | 6.1% | 250.5% | US$2.0b | US$8.25 | PE-12.1x | E118.9% | 0% | ||
MLAB | US$113.21 | -0.1% | -29.3% | US$610.7m | US$130.00 | PE644.2x | E108.3% | 0.6% | ||
YCBD | US$0.77 | -17.2% | -61.9% | US$2.4m | US$2.00 | PB0.3x | E107.1% | n/a | ||
EVOK | US$0.47 | 2.7% | -77.2% | US$4.0m | US$7.00 | PE-0.5x | E101.6% | n/a | ||
AYTU | US$3.10 | 3.0% | 46.2% | US$17.3m | US$8.00 | PB0.5x | E96.6% | n/a | ||
PLX | US$1.14 | -5.8% | -61.2% | US$83.6m | US$13.00 | PE10.1x | E96.5% | n/a | ||
ALVO | US$13.54 | -6.5% | 40.6% | US$3.9b | US$16.50 | PS40.5x | E95.2% | n/a | ||
BHC | US$7.03 | -19.7% | 18.2% | US$2.7b | US$9.79 | PE-5.7x | E95.1% | n/a | ||
CDXC | US$3.83 | 4.6% | 160.5% | US$283.2m | US$6.08 | PS3.5x | E93.2% | n/a | ||
HBIO | US$3.68 | -3.7% | -35.8% | US$159.8m | US$7.00 | PS1.5x | E93.0% | n/a | ||
RNAC | US$23.25 | -4.8% | n/a | US$413.8m | US$56.25 | PS16x | E92.4% | n/a | ||
CTKB | US$6.27 | -1.6% | -29.3% | US$837.5m | US$10.00 | PS4.3x | E92.2% | n/a | ||
CTLT | US$56.20 | -0.2% | 64.4% | US$10.2b | US$63.50 | PS2.5x | E90.1% | n/a | ||
ANIK | US$28.47 | 3.2% | 12.5% | US$417.4m | US$30.33 | PS2.5x | E89.1% | n/a | ||
CKPT | US$1.62 | 15.7% | -46.9% | US$60.3m | US$17.25 | PS561.3x | E88.1% | n/a | ||
PRPH | US$5.39 | 1.5% | -36.6% | US$97.3m | US$21.00 | PS2.2x | E87.4% | 0% |